• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输注方法对儿科患者治疗药物监测的影响。

Influence of infusion methods on therapeutic drug monitoring in pediatric patients.

作者信息

Nahata M C

出版信息

Drug Intell Clin Pharm. 1986 May;20(5):367-9. doi: 10.1177/106002808602000506.

DOI:10.1177/106002808602000506
PMID:3709347
Abstract

The purpose of this article is to emphasize the importance of infusion method on therapeutic drug monitoring in pediatric patients. Although effective serum concentrations are anticipated after intravenous infusion of drugs, studies with chloramphenicol and tobramycin have shown that the infusion method can have a profound influence on peak serum concentration and time to achieve peak concentration during therapy. Factors including infusion rate, injection site, volume of drug and fluid to be infused in the tubing, and type of infusion system should be considered for accurate drug delivery. Specific guidelines for drug infusions should be available at each institution. Since serum concentration predictions are based on the dose infused and infusion time, meaningful therapeutic monitoring data can be generated only with the understanding of the influence of infusion method on serum concentration-time profile of drugs.

摘要

本文的目的是强调输注方法在儿科患者治疗药物监测中的重要性。尽管静脉输注药物后预期会达到有效的血清浓度,但氯霉素和妥布霉素的研究表明,输注方法可对治疗期间的血清峰值浓度及达到峰值浓度的时间产生深远影响。为实现准确给药,应考虑包括输注速率、注射部位、输液管中要输注的药物和液体体积以及输注系统类型等因素。每个机构都应有具体的药物输注指南。由于血清浓度预测基于输注剂量和输注时间,因此只有了解输注方法对药物血清浓度-时间曲线的影响,才能生成有意义的治疗监测数据。

相似文献

1
Influence of infusion methods on therapeutic drug monitoring in pediatric patients.输注方法对儿科患者治疗药物监测的影响。
Drug Intell Clin Pharm. 1986 May;20(5):367-9. doi: 10.1177/106002808602000506.
2
Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics.静脉流速和注射部位对琥珀酸氯霉素体外给药及体内动力学的影响。
J Pediatr. 1981 Sep;99(3):463-6. doi: 10.1016/s0022-3476(81)80351-4.
3
Comparison of fitting methods for the analysis of plasma concentration-time data resulting from constant rate intravenous infusion.恒速静脉输注产生的血浆浓度-时间数据分析的拟合方法比较
Biopharm Drug Dispos. 1985 Jul-Sep;6(3):313-23. doi: 10.1002/bdd.2510060306.
4
[Fundamental and clinical studies on tobramycin by intravenous drip infusion (author's transl)].
Jpn J Antibiot. 1981 Nov;34(11):1436-46.
5
The effect of infusion time on the time course of drug concentration in blood.
J Pharmacokinet Biopharm. 1980 Dec;8(6):573-82. doi: 10.1007/BF01060054.
6
Intravenous infusion conditions. Implications for pharmacokinetic monitoring.静脉输注条件。对药代动力学监测的影响。
Clin Pharmacokinet. 1993 Mar;24(3):221-9. doi: 10.2165/00003088-199324030-00004.
7
Design of infusion regimens to achieve and maintain a predetermined plasma drug level range.设计输注方案以达到并维持预定的血浆药物浓度范围。
Clin Pharmacol Ther. 1980 Sep;28(3):289-95. doi: 10.1038/clpt.1980.164.
8
Influence of intravenous infusion duration on the tissue drug concentration profile.静脉输注持续时间对组织药物浓度分布的影响。
J Pharmacokinet Biopharm. 1986 Jun;14(3):323-34. doi: 10.1007/BF01106710.
9
[Pharmacokinetic studies of tobramycin using the continuous intravenous infusion method (author's transl)].
Jpn J Antibiot. 1981 Nov;34(11):1429-35.
10
General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.实现并维持恒定血浆药物浓度所需理想静脉药物输入的一般推导。利多卡因治疗的理论应用。
Eur J Clin Pharmacol. 1976;10(6):433-40. doi: 10.1007/BF00563080.

引用本文的文献

1
Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.儿童心血管药物的药代动力学。强心药和血管升压药。
Clin Pharmacokinet. 1994 Nov;27(5):345-67. doi: 10.2165/00003088-199427050-00003.
2
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.新生儿及儿童年龄组的治疗药物监测。问题及临床药代动力学影响。
Clin Pharmacokinet. 1990 Jul;19(1):1-10. doi: 10.2165/00003088-199019010-00001.